FDA
approval
· 2014-12-19
FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
Summary
FDA approved a supplemental application to add the intravenous form of Protonix (pantoprazole sodium) to Wyeth/Pfizer's product line, expanding its use for pati…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PROTONIX I.V. (PANTOPRAZOLE SODIUM)